Neutropenic Colitis After Treatment of Acute Myelogenous Leukemia With Idarubicin and Cytosine Arabinoside

This publication has 9 references indexed in Scilit:

• Neutropenic Enterocolitis: Spectrum of the Disease and Comparison of Definite and Possible Cases
  Clinical Infectious Diseases, 1998
• A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia
  British Journal of Haematology, 1998
• Editorial Response: Neutropenic Enterocolitis
  Clinical Infectious Diseases, 1998
• A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.
  Journal of Clinical Oncology, 1992
• Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia
  Blood, 1992
• A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia
  European Journal of Cancer and Clinical Oncology, 1991
• Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
  Blood, 1991
• Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: A potentiating role for amsacrine
  Annals of Hematology, 1991
• Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study
  Blood, 1982